ACTRN12609001063202
Completed
Phase 2
A randomised placebo-controlled double-blind trial with participants randomised to receive either placebo, 60,000 International Units per month (IU/month) of vitamin D3 or 30,000 IU/month of vitamin D3, each taken once a month for 12 months with an aim to determine the feasibility and inform the design of a large-scale randomised, placebo-controlled chemoprevention trial of vitamin D3 (cholecalciferol) for the reduction of total mortality.
ConditionsThis trial is using healthy volunteers from the electoral roll. The overall aim of this study is to determine the feasibility and inform the design of a large-scale randomised, placebo-controlled chemoprevention trial of vitamin D3 (cholecalciferol) for the reduction of total mortality.Public Health - Other public health
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- This trial is using healthy volunteers from the electoral roll. The overall aim of this study is to determine the feasibility and inform the design of a large-scale randomised, placebo-controlled chemoprevention trial of vitamin D3 (cholecalciferol) for the reduction of total mortality.
- Sponsor
- Queensland Institute of Medical Research
- Enrollment
- 660
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Residents in Queensland, New South Wales, Tasmania and Victoria aged between 60 and 85 years will be selected at random from the Commonwealth Electoral Roll. Half will be selected from capital cities and half from regional centres, selecting from postcodes that are within 20 kilometres of a pathology collection clinic. Selection will be stratified by state, region, age (in five\-year age bands) and sex to ensure an equal state, region, age\- and sex\-distribution.
Exclusion Criteria
- •People will be excluded if they are unable to give consent or to communicate well enough in English to understand study materials or if they indicate in an initial screening questionnaire that they:
- •1\.Have any of the following medical conditions (which either preclude or require high dose vitamin D supplementation or prevent informed consent): hyperparathyroidism, sarcoidosis, nephrolithiasis, osteomalacia, osteoporosis, a history of renal calculi or colic
- •2\. Are taking vitamin D at doses \>600IU/day
- •3\. Do not have a telephone (landline or mobile)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
ltrasound Guided Transversus Abdominis Plane Block in Major Gynaecological Surgery – A randomised controlled TrialPost-operative PainAnaesthesiology - Pain managementACTRN12608000161325James Griffiths70
Completed
Not Applicable
A double-blind randomised placebo-controlled trial of topical nasal steroids in 4-11 year old children with persistent bilateral Otitis Media with Effusion (OME) in primary careISRCTN38988331niversity of Southampton (UK)
Completed
Not Applicable
A double-blind randomised placebo-controlled trial of symptom-triggered alcohol detoxification on a general psychiatric wardISRCTN33971222Department of Health70
Completed
Not Applicable
A double-blind placebo-controlled randomised trial of oral sodium clodronate for metastatic prostate adenocarcinomaProstate cancerCancerMalignant neoplasm of prostateISRCTN38477744Medical Research Council (MRC) (UK)311
Completed
Not Applicable
A randomised double-blind placebo-controlled trial of the effect of vitamin and mineral supplements on morbidity from infections in men and women over 65 yearsMineral & vitamin supplementationNutritional, Metabolic, EndocrineISRCTN66376460Health Services Research Unit, University of Aberdeen (UK)910